{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:38Z","timestamp":1792787258934,"version":"4.5.0"},"reference-count":30,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"unspecified","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NIH","award":["R01DK24092-34"],"award-info":[{"award-number":["R01DK24092-34"]}]},{"name":"NIH","award":["Ralph DeFronzo"],"award-info":[{"award-number":["Ralph DeFronzo"]}]},{"name":"ADA","award":["DK107680"],"award-info":[{"award-number":["DK107680"]}]},{"name":"ADA","award":["Muhammad Abdul-Ghani"],"award-info":[{"award-number":["Muhammad Abdul-Ghani"]}]},{"name":"QNRF","award":["Amin Jayyousi"],"award-info":[{"award-number":["Amin Jayyousi"]}],"id":[{"id":"https:\/\/ror.org\/01svaqq28","id-type":"ROR","asserted-by":"crossref"}]},{"name":"QNRF","award":["NPRP 5-273-3-079"],"award-info":[{"award-number":["NPRP 5-273-3-079"]}],"id":[{"id":"https:\/\/ror.org\/01svaqq28","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,9,12]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1136\/bmjdrc-2026-006294","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:15:20Z","timestamp":1791890120000},"page":"e006294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of low-dose pioglitazone in combination with exenatide on glucose control in patients with T2DM"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct02887625","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4556-1787","authenticated-orcid":false,"given":"Muhammad A","family":"Abdul-Ghani","sequence":"first","affiliation":[{"name":"Diabetes Division, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"},{"name":"Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-1252","authenticated-orcid":false,"given":"Mohamed","family":"Abu-Farha","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtiss","family":"Puckett","sequence":"additional","affiliation":[{"name":"Diabetes Division, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamam","family":"Abdul-Ghani","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozde","family":"Baskoy","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"Abdelgani","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4979-3799","authenticated-orcid":false,"given":"Hussein","family":"Zaitoon","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Merovci","sequence":"additional","affiliation":[{"name":"Department of Medicine, Diabetes Division, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Adams","sequence":"additional","affiliation":[{"name":"Diabetes Division, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Triplitt","sequence":"additional","affiliation":[{"name":"UT Health San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Kanat","sequence":"additional","affiliation":[{"name":"DIMER Diabetes and Obesity Center, Istanbul Atlas Universitesi, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3839-1724","authenticated-orcid":false,"given":"Ralph A","family":"DeFronzo","sequence":"additional","affiliation":[{"name":"UT Health San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Jayyousi","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahd","family":"Al-Mulla","sequence":"additional","affiliation":[{"name":"Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"2026101304151016000_14.5.e006294.1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-9028"},{"key":"2026101304151016000_14.5.e006294.2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.12.1595"},{"key":"2026101304151016000_14.5.e006294.3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114142"},{"key":"2026101304151016000_14.5.e006294.4","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.4.710"},{"key":"2026101304151016000_14.5.e006294.5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1463-1326.2008.00880.x","article-title":"Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients","volume":"10","author":"Miyazaki","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2026101304151016000_14.5.e006294.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041001"},{"key":"2026101304151016000_14.5.e006294.7","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.3.517"},{"key":"2026101304151016000_14.5.e006294.8","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.2337\/dcS13-2003","article-title":"In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion","volume":"36 Suppl 2","author":"Eldor","year":"2013","journal-title":"Diabetes Care"},{"key":"2026101304151016000_14.5.e006294.9","doi-asserted-by":"publisher","DOI":"10.4158\/EP.9.5.406"},{"key":"2026101304151016000_14.5.e006294.10","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/628628","article-title":"Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanisms","volume":"2013","author":"Be\u0142towski","year":"2013","journal-title":"PPAR Res"},{"key":"2026101304151016000_14.5.e006294.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"2026101304151016000_14.5.e006294.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.21.joc60158"},{"key":"2026101304151016000_14.5.e006294.13","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12417"},{"key":"2026101304151016000_14.5.e006294.14","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1210\/jc.2016-3423","article-title":"Efficacy of Exenatide Plus Pioglitazone Vs Basal\/Bolus Insulin in T2DM Patients With Very High HbA1c","volume":"102","author":"Abdul-Ghani","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101304151016000_14.5.e006294.15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/dom.14383","article-title":"Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study","volume":"23","author":"Abdelgani","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2026101304151016000_14.5.e006294.16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/dom.13189","article-title":"Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal\/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study","volume":"20","author":"Abdul\u2010Ghani","year":"2018","journal-title":"Diabetes Obesity Metabolism"},{"key":"2026101304151016000_14.5.e006294.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0978"},{"key":"2026101304151016000_14.5.e006294.18","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1738"},{"key":"2026101304151016000_14.5.e006294.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.10.009"},{"key":"2026101304151016000_14.5.e006294.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206722","article-title":"Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial","volume":"13","author":"Satirapoj","year":"2018","journal-title":"PLoS ONE"},{"key":"2026101304151016000_14.5.e006294.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.05.015"},{"key":"2026101304151016000_14.5.e006294.22","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K05-067"},{"key":"2026101304151016000_14.5.e006294.23","doi-asserted-by":"publisher","DOI":"10.1177\/1470320312452028"},{"key":"2026101304151016000_14.5.e006294.24","first-page":"36","article-title":"Effect of Low (7.5 mg\/day), Standard (15 mg\/ day) and High (30 mg\/day) Dose Pioglitazone Therapy on Glycemic Control and Weight Gain in Recently-Diagnosed Type 2 Diabetes Patients","volume":"63","author":"Panikar","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"2026101304151016000_14.5.e006294.25","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12194"},{"key":"2026101304151016000_14.5.e006294.26","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.11.1605"},{"key":"2026101304151016000_14.5.e006294.27","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.diabres.2015.05.030","article-title":"Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial","volume":"109","author":"Rajagopalan","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"2026101304151016000_14.5.e006294.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.126"},{"key":"2026101304151016000_14.5.e006294.29","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14687"},{"key":"2026101304151016000_14.5.e006294.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929"}],"container-title":["BMJ Open Diabetes Research & Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2026-006294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:15:23Z","timestamp":1791890123000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2026-006294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10,13]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjdrc-2026-006294"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2026-006294","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}